Skip to main content
OpenTrials

Clinical trial condition

Megalencephaly cutis marmorata telangiectatica congenita

Explore clinical trials studying Megalencephaly cutis marmorata telangiectatica congenita. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Megalencephaly cutis marmorata telangiectatica congenita trial results

Recruiting

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

NCT06789913

Conditions
Angiomatosis, CLOVES Syndrome, Cardiovascular Abnormalities, +17 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
View all 34 locations
View Trial Details
Recruiting

Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)

NCT05577754

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CHRU Brest Brest, France
  • HCL - Groupement Hospitalier Est Hôpital Femme-Mère-Enfant Bron, France
View all 13 locations
View Trial Details

Related conditions